Ambu
Ambu A/S is a Danish medical technology company that develops, manufactures, and markets single-use medical devices for hospitals and rescue services globally. The company provides innovative diagnostic and therapeutic products across anesthesia, pulmonology, cardiology, and neurology, with a strong emphasis on sterile single-use visualization scopes and bronchoscopes. Its primary revenue drivers stem from recurring sales of disposable medical instruments that reduce cross-contamination risks and eliminate hospital instrument reprocessing costs. Operating on a major international scale, the firm serves healthcare providers worldwide through an established distribution network. The company is headquartered in Ballerup, Denmark, and its shares are publicly listed on Nasdaq Copenhagen. Through continuous clinical innovation centered on patient safety, the enterprise maintains a prominent position in the medical devices sector.
24 of the funds FundTelligence covers report a position in Ambu.
- Sector
- Health Care
- Country
- Denmark
- Funds holding it
- 24
Funds holding Ambu
- SEB Nordenfond Småbolag — SEB · 5.2 % (largest positions only, September 2026)
- Nordea Danske aktier fokus — Nordea Funds · 4.92 % (full portfolio disclosed, September 2026)
- Nordea Danmark — Nordea Funds · 4.78 % (full portfolio disclosed, September 2026)
- Danske Invest Denmark Focus — Danske Invest · 1.93 % (full portfolio disclosed, September 2026)
- SEB Europafond Småbolag — SEB · 1.75 % (full portfolio disclosed, June 2026)
- Case All Star Småbolag — Case · 1.56 % (full portfolio disclosed, June 2026)
- Nordea European Small and Mid Cap Sustainable Stars — Nordea Funds · 1.45 % (full portfolio disclosed, July 2026)
- Nordea Europa — Nordea Funds · 1.37 % (full portfolio disclosed, September 2026)
Showing the 8 largest of 24 funds holding it.